NYSE:CIVI - Civitas Solutions Stock Price, Price Target & More

Civitas Solutions trades on the New York Stock Exchange (NYSE) under the ticker symbol "CIVI."

Civitas Solutions announced that its Board of Directors has approved a stock buyback plan on Friday, February 9th 2018, which authorizes the company to repurchase $25,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to purchase shares of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's board of directors believes its stock is undervalued.

Civitas Solutions Inc (NYSE:CIVI) announced its quarterly earnings results on Thursday, May, 10th. The company reported $0.37 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.13 by $0.24. The firm earned $392.80 million during the quarter, compared to the consensus estimate of $397 million. Civitas Solutions had a net margin of 0.23% and a return on equity of 23.72%. Civitas Solutions's revenue for the quarter was up 8.4% on a year-over-year basis. During the same period last year, the company posted $0.15 EPS. View Civitas Solutions' Earnings History.

Civitas Solutions is scheduled to release their next quarterly earnings announcement on Tuesday, August, 7th 2018. View Earnings Estimates for Civitas Solutions.

5 analysts have issued twelve-month target prices for Civitas Solutions' stock. Their predictions range from $19.00 to $21.00. On average, they expect Civitas Solutions' share price to reach $20.00 in the next year. This suggests a possible upside of 22.0% from the stock's current price. View Analyst Ratings for Civitas Solutions.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Civitas Solutions in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to Civitas Solutions include Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), Addus Homecare (ADUS), BioScrip (BIOS) and New York Health Care (BBAL).

Media headlines about CIVI stock have trended somewhat positive on Saturday, Accern Sentiment Analysis reports. Accern scores the sentiment of media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Civitas Solutions earned a news impact score of 0.17 on Accern's scale. They also assigned press coverage about the company an impact score of 45.87 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

Shares of CIVI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CIVI stock can currently be purchased for approximately $16.40.

Civitas Solutions has a market capitalization of $603.27 million and generates $1.47 billion in revenue each year. The company earns $6.33 million in net income (profit) each year or $0.71 on an earnings per share basis. Civitas Solutions employs 22,900 workers across the globe.

Civitas Solutions' mailing address is 313 CONGRESS STREET 6TH FLOOR, BOSTON MA, 02210. The company can be reached via phone at 617-790-4800 or via email at [email protected]